首页> 外文期刊>Proteomics >Quantitative proteornes and in vivo secretomes of progressive and regressive UV-induced fibrosarcoma tumor cells: Mimicking tumor microenvironment using a dermis-based cell-trapped system linked to tissue chamber
【24h】

Quantitative proteornes and in vivo secretomes of progressive and regressive UV-induced fibrosarcoma tumor cells: Mimicking tumor microenvironment using a dermis-based cell-trapped system linked to tissue chamber

机译:渐进性和渐进性紫外线诱导的纤维肉瘤肿瘤细胞的定量蛋白质组和体内分泌组:使用与组织室相连的基于真皮的细胞捕获系统模拟肿瘤微环境

获取原文
获取原文并翻译 | 示例
           

摘要

The alterations of tumor proteome and/or in vivo secretome created by host-tumor cell interaction may be crucial factors for tumors to undergo progression or regression in a host system. Two UV-induced fibrosarcoma tumor cell lines (UV-2237 progressive cells and UV-2240 regressive cells) were used as models to address this issue. Hundreds of proteins including in vivo secretome have been identified and quantified via an isotope-coded protein label (ICPL) in conjunction with high-throughput NanoLC-LTQ MS analysis. A newly designed technology using a dermis-based cell-trapped system was employed to encapsulate and grow 3-D tumor cells. A tissue chamber inserted with a tumor cell-trapped dermis was implanted into mice to mimic the tumor microenvironment. The in vivo secretome created by host-tumor interaction was characterized from samples collected from tissue chamber fluids via ICPL labeling mass,spectometric analysis. Twenty-five proteins including 14-3-3 proteins, heat shock proteins, profilin-1, and a fragment of complement C3 with differential expression in proteomes of UV-2237 and UV-2240 cells were revealed. Three secreted proteins including myeloperoxidase, alpha-2-macroglobulin, and a vitamin D-binding protein have different abundances in the in vivo secretome in response to UV2237 and UV-2240 cells. Differential tumor proteomes and in vivo secretome were thus accentuated as potential therapeutic targets to control tumor growth.
机译:由宿主-肿瘤细胞相互作用产生的肿瘤蛋白质组和/或体内分泌组的改变可能是肿瘤在宿主系统中进行进展或消退的关键因素。两种紫外线诱导的纤维肉瘤肿瘤细胞系(UV-2237渐进性细胞和UV-2240退化性细胞)用作解决此问题的模型。已通过同位素编码的蛋白质标记(ICPL)结合高通量NanoLC-LTQ MS分析鉴定并定量了数百种蛋白质,包括体内分泌组。使用基于真皮的细胞捕获系统的新设计技术被用来封装和生长3-D肿瘤细胞。将装有肿瘤细胞捕获的真皮的组织腔植入小鼠体内,以模拟肿瘤的微环境。通过ICPL标记质量,光谱分析,从组织室液中收集的样品对由宿主-肿瘤相互作用产生的体内分泌组进行了表征。揭示了25种蛋白质,包括14-3-3蛋白,热休克蛋白,profilin-1和补体C3片段,它们在UV-2237和UV-2240细胞的蛋白质组中差异表达。响应于UV2237和UV-2240细胞,三种分泌的蛋白(包括髓过氧化物酶,α-2-巨球蛋白和维生素D结合蛋白)在体内的分泌组中具有不同的丰度。因此,差异性肿瘤蛋白质组和体内分泌组被强调为控制肿瘤生长的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号